[Form 4] Marvell Technology, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Marvell Technology, Inc. (MRVL) Form 4: The reporting person, Willem A. Meintjes, identified as the company's Chief Financial Officer, purchased 3,400 shares of Marvell common stock on 09/25/2025 at a price of $78.03 per share. Following this transaction, the reporting person beneficially owned 132,159 shares. The filing notes the purchase was matchable under Section 16(b) but there were no profits to disgorge. The Form 4 was signed on behalf of Mr. Meintjes by an attorney-in-fact, Blair Walters.

Positive

• Insider purchase by the CFO of 3,400 shares, signaling direct management ownership
• Proper compliance with Section 16 reporting: transaction disclosed on Form 4 and explanatory remark provided

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO purchased 3,400 shares at $78.03, modest insider buy increasing beneficial ownership to 132,159 shares.

This purchase represents a direct, non-derivative acquisition by a senior executive, which investors often view as a positive alignment of management and shareholder interests. The position size is relatively small versus typical issuer market caps, so the market-moving impact is likely limited. The Form explicitly states the trade was matchable under Section 16(b) with no disgorgement, indicating no short-swing profit issue.

Corporate Governance Expert

TL;DR: Routine insider disclosure of a personal stock purchase, properly reported via Form 4 and executed through an attorney-in-fact.

The filing complies with Section 16 reporting requirements and includes the required explanatory remark about Section 16(b). The signature by attorney-in-fact is disclosed, which is acceptable when properly authorized. There are no governance red flags or indications of undisclosed related-party arrangements in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Meintjes Willem A

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CA 95054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/25/2025		P(1)		3,400	A	$78.03	132,159	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. While the Reporting Person's purchase of the Common Stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, there were no profits to disgorge.

Remarks:

	/s/ Willem Meintjes by Blair Walters as attorney-in-fact	09/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Marvell (MRVL) Form 4 disclose?

The Form 4 reports that CFO Willem A. Meintjes purchased 3,400 shares of Marvell on 09/25/2025 at $78.03 per share.

How many shares does the reporting person own after the transaction?

Following the purchase, the reporting person beneficially owned 132,159 shares.

Was there any Section 16(b) issue disclosed in the Form 4 for MRVL?

The filing states the purchase was matchable under Section 16(b) but explicitly notes there were no profits to disgorge.

Who signed the Form 4 for the reporting person?

The Form 4 is signed by Willem Meintjes via attorney-in-fact Blair Walters with signature dated 09/25/2025.

Is the reported transaction a derivative or non-derivative trade?

The transaction is a non-derivative trade in common stock (a direct purchase).